National Cancer Institute & Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website Save this grant

Next deadline: May 7, 2024

Later deadlines: Jun 5, 2024, Jul 5, 2024, Sep 7, 2024, Oct 5, 2024, Nov 5, 2024, Jan 7, 2025, Feb 5, 2025, Mar 5, 2025, May 7, 2025, Jun 5, 2025, Jul 5, 2025, Sep 7, 2025, Oct 5, 2025, Nov 5, 2025, Jan 7, 2026, Feb 5, 2026, Mar 5, 2026, May 7, 2026, Jun 5, 2026, Jul 5, 2026, Sep 7, 2026, Oct 5, 2026, Nov 5, 2026, Jan 7, 2027

Grant amount: Up to US $2,499,995

Fields of work: Cancer/Oncology

Applicant type: Nonprofit, Government Entity, Indigenous Group, For-Profit Business

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE:  The following deadlines apply to standard grant applications (due by 5:00 pm local time of applicant organization). Optional but encouraged Letters of Intent are due 30 days prior to a Full Proposal submission.


  • February 5, 2024
  • June 5, 2024
  • October 5, 2024
  • February 5, 2025
  • June 5, 2025
  • October 5, 2025
  • February 5, 2026
  • June 5, 2026
  • October 5, 2026

The following deadlines apply to standard grant applications (due by 5:00 pm local time of applicant organization. Optional but encouraged Letters of Intent are due 30 days prior to a Full Proposal submission.

  • March 5, 2024
  • July 5, 2024
  • November 5, 2024
  • March 5, 2025
  • July 5 , 2025
  • November 5, 2025
  • March 5, 2026
  • July 5, 2026
  •  November 5, 2026

The following deadlines apply to AIDS-related grant applications (due by 5:00 pm local time of applicant organization). Optional but encouraged Letters of Intent are due 30 days prior to a Full Proposal submission.

  • May 7, 2024
  • September 7, 2024
  • January 7, 2025
  • May 7, 2025
  • September 7, 2025
  • January 7, 2026
  • May 7, 2026
  • September 7, 2026
  • January 7, 2027

The purpose of this reissuance is to seek research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

US Dept. of Health & Human Services: National Institutes of Health (NIH)
FUNDER

Your history with this funder
0
SAVED OPPORTUNITIES
No saved opportunities from this funder yet
FUNDER NOTES
Save this opportunity to add notes...
CONTACTS
Save this opportunity to add contacts...

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed December 19, 2023 and last updated December 19, 2023